Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

RAD6B overexpression confers chemoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response

Oncogene volume 23, pages 3097–3106 (2004)Cite this article

Abstract

The HR6A and HR6B genes, homologs of the yeast RAD6 gene, encode ubiquitin conjugating enzymes that are required for postreplication repair (PRR) of DNA and damage-induced mutagenesis. We show here that consistent with its role as a PRR protein, HR6 protein (referred as RAD6) expression is cell cycle regulated, with maximal levels expressed in late S/G2 phases of the cell cycle. Exposure of MCF10A cells to adriamycin (ADR) causes enhancement in the levels of RAD6B mRNA and protein. Inclusion of actinomycin D abolishes both basal and ADR-induced RAD6B transcription indicating that ADR-induced effects on RAD6B transcription result from an increase in transcriptional activity rather than from regulation of RAD6B mRNA stability. The increase in RAD6 protein expression observed in ADR-treated cells is dependent upon transcription and de novo protein synthesis, as addition of actinomycin D and cycloheximide eliminated the induction effects. Using in vivo crosslinking experiments, we demonstrate that only a small proportion of RAD6 is associated with chromatin in untreated MCF10A cells. However, treatment with ADR or cisplatin is accompanied by a significant increase and redistribution of RAD6 to DNA, and RAD6, RAD18, PCNA, phosphohistone H3, as well as p53 proteins are all found in the DNA fractions. These findings suggest that although RAD6 protein is present in the nucleus, its recruitment to the chromatin appears to be modulated by DNA damage. Whereas MCF10A cells engineered to overexpress ectopic RAD6B are significantly more resistant to ADR and cisplatin as compared to empty vector-transfected cells, MCF10A cells stably transfected with antisense RAD6B display hypersensitivity to these damage-inducing drugs. Analysis of PRR capacities in cisplatin-treated MCF10A cells stably transfected with empty vector, RAD6B or antisense RAD6B showed that whereas RAD6B-overexpressing and vector control MCF10A cells possessed the ability to convert newly synthesized DNA to higher molecular weight species, MCF10A cells depleted of RAD6B are PRR-compromised. Although no human diseases have been linked to mutations in the PRR pathway genes, these data suggest that RAD6 may play an essential role in DNA damage tolerance and recovery via modulation of PRR, and that imbalances in the levels of RAD6 could lead to changes in drug sensitivity and damage-induced mutagenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bailly V, Lauder S, Prakash S and Prakash L . (1997). J. Biol. Chem., 272, 23360–23365.

  • Broomfield S, Chow BL and Xiao W . (1998). Proc. Natl. Acad. Sci. USA, 95, 5678–5683.

  • Broomfield S, Hryciw T and Xiao W . (2001). Mutat. Res., 486, 167–184, (review).

  • Cejka P, Vondrejs V and Storchova Z . (2001). Genetics, 159, 953–963.

  • Ellison KS, Gwozd T, Prendergast JA, Paterson MC and Ellison MJ . (1991). J. Biol. Chem., 266, 24116–24120.

  • Friedberg EC, Walker GC and Siede W . (1995). DNA Repair and Mutagenesis. ASM Press: Washington, DC.

    Google Scholar 

  • Haynes RH and Kunz BA . (1981). The Molecular Biology of the Yeast Saccharomyces cerevisiae: Life Cycle and Inheritance, Strathern J, Jones E and Broach J (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor, pp. 371–414.

    Google Scholar 

  • Hoege C, Pfander B, Moldovan GL, Pyrowolakis G and Jentsch S . (2002). Nature, 419, 135–141.

  • Jentsch S, McGrath JP and Varshavsky A . (1987). Nature, 329, 131–134.

  • Kim H, You S, Farris J, Foster LK and Foster DN . (2001). Oncogene, 20, 3306–3310.

  • Koken MH, Hoogerbrugge JW, Jasper-Dekker I, de Wit J, Willemsen R, Roest HP, Grootegoed JA and Hoeijmakers JH . (1996). Dev. Biol., 173, 119–132.

  • Koken MH, Reynolds P, Jaspers-Dekker I, Prakash L, Prakash S, Bootsma D and Hoeijmakers JHJ . (1991). Proc. Natl. Acad. Sci. USA, 88, 8865–8869.

  • Koken MH, Smit EM, Jaspers-Dekkers I, Oostra BA, Hagemeijer D, Bootsma D and Hoeijmakers JH . (1992). Genomics, 12, 447–453.

  • Kupiec M and Simchen G . (1984). Curr. Genet., 8, 559–566.

  • Lawrence CW . (1982). Adv. Genet., 21, 173–254.

  • Lawrence C . (1994). BioEssays, 16, 253–258.

  • Lehman AR . (1972). J. Mol. Biol., 66, 319–337.

  • Lehman AR, Kirk-Bell S, Arlett CF, Paterson MC, Lohman PH, de Weerd-Kastelein EA and Bootsma D . (1975). Proc. Natl. Acad. Sci. USA, 72, 219–223.

  • Lyakhovich A and Shekhar MP . (2003). Mol. Cell. Biol., 23, 2463–2475.

  • McDonald JP, Levine AS and Woodgate R . (1997). Genetics, 147, 1557–1568.

  • Prakash S, Sung P and Prakash L . (1990). The Eukaryotic Nucleus. Vol. 1. Straus PR, Wilson SH (eds). Telford Press: Caldwell, NJ, pp. 275–292.

  • Reynolds P, Weber S and Prakash L . (1985). Proc. Natl. Acad. Sci. USA, 82, 168–172.

  • Roche H, Gietz RD and Kunz BA . (1995). Genetics, 140, 443–456.

  • Roest HP, van Klaveren J, de Wit J, van Gurp CG, Koken MH, Vermey M, van Roijen JH, Hoogerbrugge JW, Vreeburg JT, Baarends WM, Bootsma D, Grootegoed JA and Hoeijmakers JH . (1996). Cell, 86, 799–810.

  • Shekhar MP, Lyakhovich A, Heng H, Visscher DW and Kondrat N . (2002). Cancer Res., 62, 2115–2124.

  • Shieh SY, Ikeda M, Taya Y and Prives C . (1997). Cell, 91, 325–334.

  • Solomon MJ and Varshavsky A . (1985). Proc. Natl. Acad. Sci. USA, 82, 6470–6474.

  • Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC . (1990). Cancer Res., 50, 6075–6086.

  • Sung P, Prakash S and Prakash L . (1990). Proc. Natl. Acad. Sci. USA, 87, 2695–2699.

  • Sung P, Prakash S and Prakash L . (1991). J. Mol. Biol., 221, 745–749.

  • Torres-Ramos CA, Prakash S and Prakash L . (2002). Mol. Cell. Biol., 22, 2419–2426.

  • Ulrich HD and Jentsch S . (2000). EMBO J., 19, 3388–3397.

  • Wood A, Krogan NJ, Schneider J, Heidt J, Boateng MA, Dean K, Golshani A, Zhang Y, Greenblatt JF, Johnston M and Shilatifard A . (2002). Mol. Cell, 11, 267–273.

  • Xiao W, Chow BL, Broomfield S and Hanna M . (2000). Genetics, 155, 1633–1641.

  • Xin H, Lin W, Sumanasekera W, Zhang Y, Wu X and Wang Z . (2000). Nucleic Acids Res., 28, 2847–2854.

Download references

Acknowledgements

This work was supported by Grants DAMD17-99-I-9443 and DAMD17-02-I-0618 (to MPVS) from the US Army Medical Research and Materiel Command. We thank Dr Gloria Heppner for critical reading of the manuscript.

Author information

Authors and Affiliations

  1. Breast Cancer Program, Karmanos Cancer Institute, 110 East Warren Avenue, Detroit, 48201, MI, USA

    Alex Lyakhovich & Malathy P V Shekhar

  2. Department of Pathology, Wayne State University School of Medicine, 110 East Warren Avenue, Detroit, 48201, MI, USA

    Malathy P V Shekhar

Authors
  1. Alex Lyakhovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Malathy P V Shekhar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Malathy P V Shekhar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lyakhovich, A., Shekhar, M. RAD6B overexpression confers chemoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response. Oncogene 23, 3097–3106 (2004). https://doi.org/10.1038/sj.onc.1207449

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207449

Keywords

This article is cited by

Search

Advanced search

Quick links